Screener
Tenaya Therapeutics, Inc. TNYA Q1 2026 earnings
Reported May 6, 2026 · Before market open
Revenue$225.0KMiss by $7.3M
EPS-$0.09In line
Revenue estimate$7.5M
EPS estimate-$0.09
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$800.0K
EPS estimate-$0.10
Versus estimates
Revenue
Q2 2026$1.1MMiss by $8.9M
Q1 2026$225.0KMiss by $7.3M
FAQ
- When did Tenaya Therapeutics, Inc. report Q1 2026 earnings?
- Tenaya Therapeutics, Inc. (TNYA) reported Q1 2026 earnings on May 6, 2026 before market open.
- What were Tenaya Therapeutics, Inc.'s Q1 2026 revenue and EPS?
- Tenaya Therapeutics, Inc. reported revenue of $225.0K and eps of $-0.09 for Q1 2026.
- Did Tenaya Therapeutics, Inc. beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $7.5M by $7.3M. EPS beat the consensus estimate of $-0.09 by $0.00.
- How did Tenaya Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 62.5% from $-0.24.
- Where can I find Tenaya Therapeutics, Inc.'s Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-208975) and the 10-Q periodic report (0001193125-26-209084) directly on SEC EDGAR. The filing index links above go to sec.gov.
